In the BioHarmony Drug Report Database

"Preview" Icon

Mecasermin

Increlex (mecasermin) is a protein pharmaceutical. Mecasermin was first approved as Increlex on 2005-08-30. It has been approved in Europe to treat laron syndrome. The pharmaceutical is active against insulin-like growth factor I. In addition, it is known to target insulin-like growth factor 1 receptor.

 

Trade Name

 

Increlex
 

Common Name

 

mecasermin
 

ChEMBL ID

 

CHEMBL1201716
 

Indication

 

laron syndrome
 

Drug Class

 

Growth factors: insulin-like growth factors

Image (chem structure or protein)

Mecasermin structure rendering